Cox John
Insider CIK 1498428 · BIVV Chief Executive Officer, Director · DYN See Remarks, Director · SGTX Director · RGEN Director · BIIB EVP Pharmaceutical Oper & Tech
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DYN Dyne Therapeutics, Inc. | S Sale | 2026-09-08 | 2026-09-08 | 5,658 | $18.88 | $106.8K | 357,507 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2026-09-08 | 2026-09-08 | 5,658 | $18.88 | $106.8K | 357,507 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2026-08-13 | 2026-08-17 | 4,986 | $26.28 | $131.0K | 363,165 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2026-08-13 | 2026-08-17 | 4,986 | $26.28 | $131.0K | 363,165 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2026-06-16 | 2026-06-17 | 2,683 | $18.33 | $49.2K | 368,151 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2026-05-13 | 2026-05-14 | 3,311 | $18.36 | $60.8K | 370,834 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2026-03-05 | 2026-03-06 | 2,732 | $14.90 | $40.7K | 374,145 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | A Award deriv | 2026-02-12 | 2026-02-17 | 285,000 | — | $0 | 285,000 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | A Award | 2026-02-12 | 2026-02-17 | 180,000 | — | $0 | 376,877 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2025-12-05 | 2025-12-05 | 2,662 | $20.72 | $55.2K | 196,877 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2025-09-05 | 2025-09-09 | 2,640 | $13.41 | $35.4K | 199,539 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | A Award deriv | 2025-07-16 | 2025-07-18 | 197,285 | — | $0 | 197,285 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | G Gift | 2025-07-15 | 2025-07-15 | 10,000 | — | $0 | 202,179 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | G Gift | 2025-07-15 | 2025-07-15 | 10,000 | — | $0 | 222,179 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | G Gift | 2025-07-15 | 2025-07-15 | 10,000 | — | $0 | 212,179 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | G Gift | 2025-07-15 | 2025-07-15 | 10,000 | — | $0 | 232,179 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | P Buy | 2025-07-14 | 2025-07-15 | 100,000 | $9.11 | $911.0K | 242,179 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2025-06-05 | 2025-06-06 | 4,060 | $13.35 | $54.2K | 142,179 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2025-03-05 | 2025-03-07 | 4,061 | $11.83 | $48.0K | 146,239 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | A Award deriv | 2024-12-04 | 2024-12-06 | 232,100 | — | $0 | 232,100 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | A Award | 2024-12-04 | 2024-12-06 | 145,300 | — | $0 | 150,300 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | P Buy | 2024-09-04 | 2024-09-04 | 800 | $32.57 | $26.1K | 800 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | P Buy | 2024-09-04 | 2024-09-04 | 7,200 | $33.09 | $238.2K | 8,000 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | P Buy | 2024-09-04 | 2024-09-04 | 800 | $32.57 | $26.1K | 800 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | P Buy | 2024-09-04 | 2024-09-04 | 7,200 | $33.09 | $238.2K | 8,000 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | P Buy | 2024-09-04 | 2024-09-04 | 800 | $32.57 | $26.1K | 800 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | P Buy | 2024-09-04 | 2024-09-04 | 7,200 | $33.09 | $238.2K | 8,000 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | P Buy | 2024-09-04 | 2024-09-04 | 800 | $32.57 | $26.1K | 800 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | P Buy | 2024-09-04 | 2024-09-04 | 7,200 | $33.09 | $238.2K | 8,000 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | A Award deriv | 2024-03-25 | 2024-03-27 | 679,853 | — | $0 | 679,853 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | D To issuer deriv | 2023-08-11 | 2023-08-11 | 683 | $5.00 | $3.4K | 0 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | D To issuer deriv | 2023-08-11 | 2023-08-11 | 683 | $6.64 | $4.5K | 0 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | D To issuer | 2023-08-11 | 2023-08-11 | 341 | — | $0 | 0 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | A Award deriv | 2023-05-19 | 2023-05-22 | 8,888 | — | $0 | 8,888 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | A Award deriv | 2022-05-26 | 2022-05-27 | 8,888 | — | $0 | 8,888 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | A Award deriv | 2021-06-24 | 2021-06-28 | 8,888 | $9.97 | $88.6K | 8,888 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | C Conversion deriv | 2020-12-08 | 2020-12-10 | 4,444 | — | $0 | 0 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | C Conversion | 2020-12-08 | 2020-12-10 | 4,444 | — | $0 | 4,444 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-03-24 | 2020-03-26 | 1,858 | $96.72 | $179.7K | 923 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2020-03-18 | 2020-03-20 | 3,304 | — | $0 | 0 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2020-03-18 | 2020-03-20 | 14,000 | — | $0 | 0 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2020-03-18 | 2020-03-20 | 3,632 | — | $0 | 0 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2020-03-18 | 2020-03-20 | 3,366 | — | $0 | 0 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2020-03-18 | 2020-03-20 | 2,434 | — | $0 | 0 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2020-03-18 | 2020-03-20 | 3,304 | $42.07 | $139.0K | 29,517 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2020-03-18 | 2020-03-20 | 2,434 | $38.76 | $94.3K | 26,213 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2020-03-18 | 2020-03-20 | 3,366 | $26.12 | $87.9K | 23,779 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-03-18 | 2020-03-20 | 1,016 | $97.17 | $98.7K | 2,781 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2020-03-18 | 2020-03-20 | 14,000 | $12.91 | $180.7K | 16,781 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-03-18 | 2020-03-20 | 24,533 | $95.13 | $2.33M | 4,984 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-03-18 | 2020-03-20 | 1,187 | $96.45 | $114.5K | 3,797 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2020-03-18 | 2020-03-20 | 3,632 | $41.19 | $149.6K | 20,413 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2020-03-04 | 2020-03-05 | 10,000 | — | $0 | 14,000 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2020-03-04 | 2020-03-05 | 10,000 | $12.91 | $129.1K | 12,781 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-03-04 | 2020-03-05 | 10,000 | $93.39 | $933.9K | 2,781 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-02-24 | 2020-02-26 | 4,355 | $92.76 | $404.0K | 2,781 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-02-24 | 2020-02-26 | 100 | $94.85 | $9.5K | 7,136 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2019-05-15 | 2019-05-17 | 2,109 | — | $0 | 2,109 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2019-05-15 | 2019-05-17 | 923 | — | $0 | 7,236 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2018-05-16 | 2018-05-17 | 3,304 | — | $0 | 3,304 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2018-05-16 | 2018-05-17 | 1,486 | — | $0 | 6,313 | SEC↗ |
| BIVV Bioverativ Inc. | D To issuer deriv | 2018-03-08 | 2018-03-08 | 193,683 | — | $0 | 0 | SEC↗ |
| BIVV Bioverativ Inc. | D To issuer deriv | 2018-03-08 | 2018-03-08 | 387,366 | — | $0 | 0 | SEC↗ |
| BIVV Bioverativ Inc. | D To issuer deriv | 2018-03-08 | 2018-03-08 | 136,364 | — | $0 | 0 | SEC↗ |
| BIVV Bioverativ Inc. | D To issuer deriv | 2018-03-08 | 2018-03-08 | 48,678 | — | $0 | 0 | SEC↗ |
| BIVV Bioverativ Inc. | D To issuer deriv | 2018-03-08 | 2018-03-08 | 48,230 | — | $0 | 0 | SEC↗ |
| BIVV Bioverativ Inc. | D To issuer | 2018-03-08 | 2018-03-08 | 185,094 | — | $0 | 0 | SEC↗ |
| BIVV Bioverativ Inc. | F Tax w/h | 2018-02-23 | 2018-02-26 | 5,794 | $104.74 | $606.9K | 185,094 | SEC↗ |
| BIVV Bioverativ Inc. | F Tax w/h | 2018-02-22 | 2018-02-26 | 13,973 | $104.30 | $1.46M | 190,888 | SEC↗ |
| BIVV Bioverativ Inc. | M Exercise deriv | 2018-02-14 | 2018-02-15 | 24,339 | — | $0 | 48,678 | SEC↗ |
| BIVV Bioverativ Inc. | F Tax w/h | 2018-02-14 | 2018-02-15 | 10,819 | $103.52 | $1.12M | 204,861 | SEC↗ |
| BIVV Bioverativ Inc. | M Exercise | 2018-02-14 | 2018-02-15 | 24,339 | — | $0 | 215,680 | SEC↗ |
| BIVV Bioverativ Inc. | M Exercise deriv | 2018-02-11 | 2018-02-13 | 18,381 | — | $0 | 0 | SEC↗ |
| BIVV Bioverativ Inc. | F Tax w/h | 2018-02-11 | 2018-02-13 | 7,672 | $103.05 | $790.6K | 191,341 | SEC↗ |
| BIVV Bioverativ Inc. | M Exercise | 2018-02-11 | 2018-02-13 | 18,381 | $9.53 | $175.2K | 199,013 | SEC↗ |
| BIVV Bioverativ Inc. | A Award deriv | 2018-01-31 | 2018-02-02 | 136,364 | — | $0 | 136,364 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2017-05-18 | 2017-05-22 | 2,434 | — | $0 | 2,434 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2017-05-18 | 2017-05-22 | 1,206 | — | $0 | 4,827 | SEC↗ |
| BIVV Bioverativ Inc. | F Tax w/h | 2017-03-31 | 2017-04-03 | 8,416 | $54.46 | $458.3K | 180,632 | SEC↗ |
| BIVV Bioverativ Inc. | A Award deriv | 2017-02-28 | 2017-03-02 | 18,381 | — | $0 | 18,381 | SEC↗ |
| BIVV Bioverativ Inc. | A Award deriv | 2017-02-28 | 2017-03-02 | 48,230 | — | $0 | 48,230 | SEC↗ |
| BIVV Bioverativ Inc. | F Tax w/h | 2017-02-28 | 2017-03-02 | 2,641 | $49.56 | $130.9K | 202,210 | SEC↗ |
| BIVV Bioverativ Inc. | A Award | 2017-02-28 | 2017-03-02 | 211,679 | — | $0 | 226,979 | SEC↗ |
| BIVV Bioverativ Inc. | F Tax w/h | 2017-02-28 | 2017-03-02 | 3,404 | $43.42 | $147.8K | 223,575 | SEC↗ |
| BIVV Bioverativ Inc. | F Tax w/h | 2017-02-28 | 2017-03-02 | 3,383 | $49.56 | $167.7K | 220,192 | SEC↗ |
| BIVV Bioverativ Inc. | F Tax w/h | 2017-02-28 | 2017-03-02 | 6,726 | $43.42 | $292.0K | 189,048 | SEC↗ |
| BIVV Bioverativ Inc. | F Tax w/h | 2017-02-28 | 2017-03-02 | 6,436 | $47.76 | $307.4K | 195,774 | SEC↗ |
| BIVV Bioverativ Inc. | F Tax w/h | 2017-02-28 | 2017-03-02 | 6,986 | $43.42 | $303.3K | 204,851 | SEC↗ |
| BIVV Bioverativ Inc. | F Tax w/h | 2017-02-28 | 2017-03-02 | 8,355 | $47.76 | $399.0K | 211,837 | SEC↗ |
| BIVV Bioverativ Inc. | A Award deriv | 2017-02-14 | 2017-02-16 | 193,337 | — | $0 | 193,337 | SEC↗ |
| BIVV Bioverativ Inc. | A Award deriv | 2017-02-14 | 2017-02-16 | 73,017 | — | $0 | 73,017 | SEC↗ |
| BIVV Bioverativ Inc. | A Award deriv | 2017-02-14 | 2017-02-16 | 386,675 | — | $0 | 386,675 | SEC↗ |
| BIVV Bioverativ Inc. | A Award deriv | 2017-02-14 | 2017-03-27 | 387,366 | — | $0 | 387,366 | SEC↗ |
| BIVV Bioverativ Inc. | A Award deriv | 2017-02-14 | 2017-03-27 | 193,683 | — | $0 | 193,683 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2016-05-11 | 2016-05-13 | 3,366 | — | $0 | 3,366 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2016-05-11 | 2016-05-13 | 1,763 | — | $0 | 3,621 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2016-04-01 | 2016-04-05 | 8,444 | — | $0 | 39,045 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2016-02-23 | 2016-02-25 | 1,608 | — | $0 | 4,842 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2016-02-23 | 2016-02-25 | 810 | — | $0 | 6,450 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2016-02-23 | 2016-02-25 | 810 | — | $0 | 30,898 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2016-02-23 | 2016-02-25 | 382 | $258.99 | $98.9K | 30,516 | SEC↗ |
| BIIB BIOGEN INC. | A Award deriv | 2016-02-22 | 2016-02-24 | 11,850 | — | $0 | 11,850 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2016-02-12 | 2016-02-17 | 1,052 | — | $0 | 3,842 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2016-02-12 | 2016-02-17 | 2,246 | — | $0 | 2,249 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2016-02-12 | 2016-02-17 | 1,394 | — | $0 | 2,448 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2016-02-12 | 2016-02-17 | 495 | $247.22 | $122.4K | 28,899 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2016-02-12 | 2016-02-17 | 2,246 | — | $0 | 31,145 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2016-02-12 | 2016-02-17 | 1,057 | $247.22 | $261.3K | 30,088 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2016-02-12 | 2016-02-17 | 1,052 | — | $0 | 29,394 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2016-02-08 | 2016-02-09 | 4,026 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2016-02-08 | 2016-02-09 | 1,324 | $250.77 | $332.0K | 28,342 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2016-02-08 | 2016-02-09 | 4,026 | — | $0 | 29,666 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2015-05-21 | 2015-05-26 | 3,632 | — | $0 | 3,632 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2015-05-21 | 2015-05-26 | 1,858 | — | $0 | 1,858 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2015-03-25 | 2015-03-26 | 2,175 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2015-03-25 | 2015-03-26 | 2,891 | — | $0 | 2,892 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2015-03-25 | 2015-03-26 | 2,891 | $60.56 | $175.1K | 37,577 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2015-03-25 | 2015-03-26 | 12,010 | $449.06 | $5.39M | 25,567 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2015-03-25 | 2015-03-26 | 2,175 | $72.87 | $158.5K | 34,686 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award deriv | 2015-02-23 | 2015-02-25 | 7,260 | — | $0 | 7,260 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2015-02-12 | 2015-02-17 | 1,492 | — | $0 | 5,848 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2015-02-12 | 2015-02-17 | 2,246 | — | $0 | 4,495 | SEC↗ |
| BIIB BIOGEN IDEC INC. | J Other deriv | 2015-02-12 | 2015-02-17 | 954 | — | $0 | 4,894 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2015-02-12 | 2015-02-17 | 2,246 | — | $0 | 32,780 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2015-02-12 | 2015-02-17 | 1,058 | $392.11 | $414.9K | 31,722 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2015-02-12 | 2015-02-17 | 1,492 | — | $0 | 33,214 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2015-02-12 | 2015-02-17 | 703 | $392.11 | $275.7K | 32,511 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2015-02-09 | 2015-02-10 | 4,691 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2015-02-09 | 2015-02-10 | 4,691 | — | $0 | 32,744 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2015-02-09 | 2015-02-10 | 2,210 | $396.88 | $877.1K | 30,534 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2015-02-08 | 2015-02-10 | 4,023 | — | $0 | 4,026 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2015-02-08 | 2015-02-10 | 1,537 | $402.00 | $617.9K | 28,053 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2015-02-08 | 2015-02-10 | 4,023 | — | $0 | 29,590 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2014-02-23 | 2014-02-25 | 2,598 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2014-02-23 | 2014-02-25 | 1,228 | $347.11 | $426.3K | 25,478 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2014-02-23 | 2014-02-25 | 2,598 | — | $0 | 26,706 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award deriv | 2014-02-12 | 2014-02-14 | 7,340 | — | $0 | 7,340 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2014-02-12 | 2014-02-14 | 2,246 | — | $0 | 6,741 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2014-02-12 | 2014-02-14 | 2,246 | — | $0 | 25,167 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2014-02-12 | 2014-02-14 | 1,059 | $323.04 | $342.1K | 24,108 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2014-02-09 | 2014-02-11 | 4,691 | — | $0 | 4,691 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2014-02-09 | 2014-02-11 | 4,691 | — | $0 | 25,133 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2014-02-09 | 2014-02-11 | 2,212 | $315.54 | $698.0K | 22,921 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2014-02-08 | 2014-02-11 | 4,023 | — | $0 | 8,049 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2014-02-08 | 2014-02-11 | 1,441 | $315.54 | $454.7K | 20,442 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2014-02-08 | 2014-02-11 | 4,023 | — | $0 | 21,883 | SEC↗ |
| BIIB BIOGEN IDEC INC. | G Gift | 2013-11-25 | 2013-12-04 | 200 | — | $0 | 17,860 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2013-11-15 | 2013-11-19 | 24,000 | — | $0 | 24,000 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2013-05-03 | 2013-05-07 | 866 | $218.85 | $189.5K | 18,060 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2013-02-23 | 2013-02-26 | 2,598 | — | $0 | 2,598 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2013-02-23 | 2013-02-26 | 2,598 | — | $0 | 19,986 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2013-02-23 | 2013-02-26 | 1,227 | $164.40 | $201.7K | 18,759 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award deriv | 2013-02-12 | 2013-02-14 | 8,987 | — | $0 | 8,987 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2013-02-09 | 2013-02-12 | 4,692 | — | $0 | 9,382 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2013-02-09 | 2013-02-12 | 1,836 | $164.44 | $301.9K | 17,388 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2013-02-09 | 2013-02-12 | 4,692 | — | $0 | 19,224 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2013-02-08 | 2013-02-12 | 3,487 | — | $0 | 12,608 | SEC↗ |
| BIIB BIOGEN IDEC INC. | J Other deriv | 2013-02-08 | 2013-02-12 | 536 | — | $0 | 12,072 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2013-02-08 | 2013-02-12 | 3,487 | — | $0 | 15,665 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2013-02-08 | 2013-02-12 | 1,133 | $164.44 | $186.3K | 14,532 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2012-05-03 | 2012-05-04 | 765 | $134.26 | $102.7K | 12,178 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2012-02-24 | 2012-02-27 | 785 | $116.39 | $91.4K | 13,506 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2012-02-24 | 2012-02-27 | 793 | $116.39 | $92.3K | 12,713 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2012-02-23 | 2012-02-27 | 2,600 | — | $0 | 5,196 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2012-02-23 | 2012-02-27 | 2,600 | — | $0 | 15,376 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2012-02-23 | 2012-02-27 | 1,085 | $116.70 | $126.6K | 14,291 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2012-02-09 | 2012-02-13 | 4,692 | — | $0 | 14,074 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2012-02-09 | 2012-02-13 | 1,504 | $117.78 | $177.1K | 12,776 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2012-02-09 | 2012-02-13 | 4,692 | — | $0 | 14,280 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award deriv | 2012-02-08 | 2012-02-10 | 16,095 | — | $0 | 16,095 | SEC↗ |